When overexpressed (up to 2 × 106 receptors/cell), HER2 promotes cell growth beyond normal limits and this is associated with an aggressive breast cancer phenotype and a poor prognosis [33,34,35]. This evidence concerns the gene ERBB2 and breast carcinoma.